Injective coin rose by over 12% today, thanks to several major events. These include a new partnership with Musicow for music IP, a Binance.US spot listing, the CLARITY Act passing the Senate Banking Committee, and the SEC’s upcoming ‘innovation exemption’ for tokenized stocks. All of these happened within days, raising 24-hour trading volume to $161 million and boosting the market cap to $510.08 million.
Injective Price Jumps as Tokenization Sector Heats Up
The Musicow partnership is one of the main drivers behind this move. Since 2017, Musicow has operated in South Korea, growing to 1.2 million members and handling about $293 million in volume across 20,000 music IP rights.
Musicow US, backed by Roc Nation, launched in early 2025 as a regulated Music Equity Service Provider, adding compliance infrastructure. Injective provides the global settlement layer via its native RWA module, launched in January 2024. It offers sub-second block finality and connects to IBC, Ethereum, and Solana, features that Musicow could not build alone.
Goldman Sachs projects the total music market at $200 billion by 2035, against a music copyright value of $47.2 billion in 2024, nearly double what it was a decade earlier.
READ MORE: $1.5 Trillion SpaceX IPO is Nearing: Top Stocks and ETFs to Buy
On-chain RWA value sits near $32 billion, covering Treasuries, private credit, and institutional money market funds. Music IP is almost nonexistent across those categories, suggesting Musicow is entering a brand-new market.
The policy backdrop is moving in the same direction. The Trump administration is preparing to roll out an “innovation exemption” that would open legal pathways for trading digital versions of securities on crypto platforms, a structural shift that stands to pull institutional capital deeper into on-chain finance.
Ondo Finance coin, the sector’s benchmark tokenization name, gained over 16% on the same session, confirming this is a rotation into the tokenization theme, not an isolated INJ catalyst. When sector leaders move together on policy news, the underlying narrative is the one doing the work.
Injective (INJ) already has a strong lineup. Its iAssets cover major equities like Nvidia, Apple, and Google, as well as a TradFi Index. Pre-IPO tokenized stocks for SpaceX, OpenAI, and Anthropic are now trading live on Injective blockchain-based DEX, Helix. The Republic pre-IPO launch alone cleared roughly $1 billion in volume within 30 days of August 2025.
INJ Price Outlook After Breaking Key Resistance
Injective coin is testing the 0.236 Fibonacci retracement, which is the first major level to reclaim after a long bear cycle. The setup for this test looks solid.
After months of forming a rounded bottom, Injective price made a sharp move that broke the main downward trendline and confirmed a shift to a bullish market structure. Now, the chart shows higher highs and higher lows, and shows signs of seller exhaustion, steady accumulation, and a breakout from the downtrend.
The bull flag compressing beneath current highs is continuation behavior, not distribution, though a shallow pullback before the next expansion leg is the more realistic path than an immediate vertical move. Support at $4.30–$4.50 is the line that keeps the structure intact.
For the Injective coin price outlook: if the price breaks above $5.60 with strong volume, the next targets are $7.41 and then $8.88. A move to the 0.618 golden pocket at $10.35 would confirm a full trend reversal. If the price falls below $4.00, the bullish case is invalidated.
READ MORE: Echo Protocol Hacked on Monad, Attacker Mints $76M in Unbacked eBTC
